Related Experiment Video
Updated: Apr 18, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER
Sandeep Sreevalsan1, Stephen Safe2
1VMR 1197, Room 413, Texas A&M University, College Station, TX, 77843 979-845-9182 ssreevalsan@cvm.tamu.edu.
Abstract:
Several agents used for treatment of colon and other cancers induce reactive oxygen species (ROS) and this plays an important role in their anticancer activities. In addition to the well-known proapoptotic effects of ROS inducers, these compounds also decrease expression of specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 and several pro-oncogenic Spregulated genes important for cancer cell proliferation, survival and metastasis. The mechanism of these responses involve ROS-dependent downregulation of microRNA-27a (miR-27a) or miR-20a (and paralogs) and induction of two Sp-repressors, ZBTB10 and ZBTB4 respectively. This pathway significantly contributes to the anticancer activity of ROS inducers and should be considered in development of drug combinations for cancer chemotherapy.
Insights
Reactive oxygen species (ROS) are key in cancer treatment by inducing apoptosis and downregulating Sp transcription factors. This mechanism, involving microRNAs and Sp repressors, offers new avenues for combination cancer chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Reactive oxygen species (ROS) play a crucial role in the anticancer activity of various therapeutic agents.
- ROS inducers not only promote apoptosis but also affect gene expression critical for cancer progression.
Purpose of the Study:
- To elucidate the molecular mechanisms by which ROS inducers exert their anticancer effects.
- To investigate the role of Sp transcription factors and their regulatory pathways in ROS-mediated cancer therapy.
Main Methods:
- Analysis of ROS-dependent changes in Sp transcription factor (Sp1, Sp3, Sp4) expression.
- Investigation of microRNA (miR-27a, miR-20a) regulation in response to ROS.
- Assessment of Sp-repressor gene induction (ZBTB10, ZBTB4) under ROS treatment.
Main Results:
- ROS inducers were found to decrease the expression of Sp1, Sp3, and Sp4 transcription factors.
- ROS-dependent downregulation of miR-27a and miR-20a was observed.
- The study identified the induction of Sp-repressors ZBTB10 and ZBTB4 as a key downstream effect.
Conclusions:
- The ROS-mediated pathway involving microRNAs and Sp-repressor induction significantly contributes to anticancer effects.
- This pathway represents a promising target for developing novel combination therapies for various cancers.
- Understanding this mechanism can guide the rational design of more effective cancer chemotherapy regimens.
More Related Videos
04:53Detection of Total Reactive Oxygen Species in Adherent Cells by 2',7'-Dichlorodihydrofluorescein Diacetate Staining
Published on: June 23, 2020
09:31Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
Published on: September 17, 2021
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Oxygen Requirements and Growth Patterns
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Radical Autoxidation
Peroxisomes
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...